Image

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

Comparing two treatments for high-risk smoldering multiple myeloma.

Recruiting
18 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is testing a new medicine called linvoseltamab to see if it works better than another medicine, daratumumab, in people with High-Risk Smoldering Multiple Myeloma (HR-SMM). Smoldering Multiple Myeloma is a condition where abnormal cells in the bone marrow do not cause symptoms yet but may develop into multiple myeloma, a type of blood cancer. The study aims to find out if linvoseltamab can delay this progression better than daratumumab. Researchers are also checking for side effects, how much medicine stays in the blood, and if the body reacts against the medicine.

  • Participants will need to have regular check-ups and follow study rules.
  • It is important to not have certain health conditions or previous treatments.
  • Participants may learn more about the safety and effects of the new drug.
Print
Study details
    High Risk Smoldering Multiple Myeloma (HR-SMM)

NCT07393282

Regeneron Pharmaceuticals

19 September 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.